A California federal judge has denied SomaLogic’s request to dismiss a case brought by a former employee who argues he’s owed unvested stock.
The case traces back to Ashwin Gopinath, the co-founder of a company bought by SomaLogic in 2022. Gopinath joined SomaLogic as a senior director of assay development, securing a pay package that included more than $1.6 million in cash and more than 76,000 shares of the biotech’s stock. His total stock compensation of 450,000-plus shares would vest over several years if he remained employed, according to court documents.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.